Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ISLB 2022 | Current limitations of liquid biopsy

Eloisa Jantus-Lewintre • 17 Oct 2022
ISLB 2022
General

Eloisa Jantus-Lewintre, PhD, Universitat Politècnica De València, Valencia, Spain, discusses the current technical limitations of liquid biopsy and emphasises the need for high sensitivity if liquid biopsy is to be used for cancer monitoring. This interview took place at the International Society of Liquid Biopsy (ISLB) 2022 congress in Miami, FL.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Eloisa Jantus-Lewintre

1:47
Selecting the best method of liquid biopsy for different cancers
Eloisa Jantus-Lewintre • 17 Oct 2022
1:46
The role of liquid biopsy in cancer monitoring
Eloisa Jantus-Lewintre • 17 Oct 2022

Related Videos

1:56
Phase I trial of trastuzumab deruxtecan and neratinib in HER2-altered tumors
Haeseong Park • 8 Apr 2024
2:45
Remaining challenges in treating solid tumors with CAR-Treg therapy
Leonardo Ferreira • 8 Apr 2024
2:01
Engineering chimeric antigen receptor regulatory T cells for treating cancer
Leonardo Ferreira • 8 Apr 2024
0:59
What challenges are there in using CAR-T cells for solid tumors?
Leonardo Ferreira • 8 Apr 2024
The content of VJOncology is intended for healthcare professionals